Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-CLOVER: ICG for Parathyroid Perfusion Assessment
NCT06579430Phase 1Completed
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of indocyanine green in thyroid cancer, Graves' disease and goiter (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Injection speed, ICG concentration and 2 more. Started Nov 2020; status: completed.
02
Drugs
indocyanine green
03
Conditions
thyroid cancerGraves' diseasegoiter
Beyond the preview
Go deeper on NCT06579430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579430.